The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders

摘要

Steroid compounds having increased resistance against metabolism and increased water solubility are disclosed, together with methods for their production. These substances are suitable for the manufacture of pharmaceuticals for the treatment of steroid related or steroid induced CNS disorders and for use in methods of prevention, alleviation or treatment of such disorders.